|
Announcements
FISHER & PAYKEL, CORP. SELECTS CLINIVATION
WORLDVIEW®.
Leading designer, manufacturer and marketer of products and
systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea selects
clinivation WorldView as its most comprehensive, authoritative, and up-to-date resource for building
its medical product submissions and registrations worldwide.
Natick, MA, February
19, 2010 - clinivation, Inc. announced today Fisher & Paykel, Corp.
selected the clinivation WorldView enterprise solution for On-Demand
Global Regulatory Intelligence.
“Fisher & Paykel is leading designer, manufacturer and marketer of products and
systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea.
We are pleased that they have chosen clinivation WorldView for comprehensive, authoritative,
and up-to-date global regulatory intelligence,” said Richard Morroney,
R.A.C., C.Q.A., clinivation's Vice President, Global Market Clearance
Solutions.
About clinivation WorldView On-Demand Global Regulatory Intelligence
Clinivation WorldView is the medical device and diagnostic industry's most comprehensive,
authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory
Intelligence. Providing clear, step-by-step market clearance regulations, processes,
and guidance for >99% of the world markets, only clinivation WorldView delivers
tried-and-true intelligence from certified, practicing professionals with real-world
experience.
About Fisher & Paykel, Corp.
Headquartered in New Zealand, Fisher & Paykel Healthcare
(NZSX:FPH, ASX:FPH) is a leading designer, manufacturer and marketer
of products and systems for use in respiratory care, acute care
and the treatment of obstructive sleep apnea. The company’s products
are sold in over 120 countries worldwide.
For more information about Fisher & Paykel, please visit www.fphcare.com
About clinivation, Inc. Clinivation
is the leading provider of integrated solutions that enable global market clearance.
Guided by our singular vision - "Excellence in Market Clearance" - clinivation
accelerates the entire market clearance cycle to advance new worldwide revenue
and achieve new milestones of enterprise value. Used in over 1,000,000 product
registrations by more than 100 companies worldwide, clinivation's end-to-end technology
and services deliver on our vision by eliminating revenue traps from global market
clearance operations, increasing process velocity with on-demand regulatory intelligence,
automating clearance-driven business controls, simplifying content unification
into market clearance applications, aligning quality systems with global market
clearance priorities, streamlining clinical development with clearance-focused
trials, and enabling management with key performance indicators for continuous
improvement and effective governance. The world's leading medical device,
diagnostics, hospital supply, and dental supply companies select clinivation because
of our medtech industry focus and our unique, integrated solutions that seamlessly
adapt to existing business processes and enterprise infrastructure- without the
need to write custom code. Our core brands include the clinivation Global xi
market clearance platform, clinivation WorldView on-demand regulatory intelligence,
and clinivation Clinical Suite and clinivation Registry Suite electronic data
capture and clinical data management software. Founded in 1999, the company
is headquartered in Natick, Massachusetts, with regional offices in North America
and Asia. Visit clinivation online at www.clinivation.com For
further information: For more information on clinivation's
integrated solutions that enable global market clearance, please click
here or call us at 508.655.6560. | 
